NextCell Pharma AB (FRA:65G)
Germany · Delayed Price · Currency is EUR 0.0474
-0.0015 (-3.07%)
At close: Dec 19, 2025
NextCell Pharma AB Market Cap
NextCell Pharma AB has a market cap or net worth of €6.85 million as of December 19, 2025. Its market cap has decreased by -40.07% in one year.
Market Cap
6.85M
Enterprise Value
3.28M
Revenue
998.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.05
Market Cap Chart
Since July 13, 2017, NextCell Pharma AB's market cap has increased from 3.47M to 6.85M, an increase of 97.57%. That is a compound annual growth rate of 8.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 6.85M | -62.20% |
| Dec 30, 2024 | 18.11M | 123.33% |
| Dec 29, 2023 | 8.11M | -62.67% |
| Dec 30, 2022 | 21.73M | -16.60% |
| Dec 30, 2021 | 26.05M | -36.85% |
| Dec 30, 2020 | 41.25M | 213.74% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |